Additionally, use of keratinocytes from biopsies of subjects with AD treated with and without AHR ligands, such as tapinarof, would provide much more direct comparisons of the effects of AHR activation in AD than in vitro models. This evidence concerns the gene AHR and Alzheimer disease.